Mitigation Measures for Water Pollution and Flooding

This chapter discusses the range of measures that can be used to mitigate the impacts of water pollution and flooding. It makes a distinction between source measures which aim to reduce the amount of water or pollutant initially mobilised, pathway interventions which seek to slow the flow of pollutant enriched water once it has become mobilised and methods to protect receptor water bodies which are intended to reduce peak flows or prevent pollutants moving further through a catchment. In many European countries the policies and programmes used to increase the adoption of such measures are heavily influenced by EU obligations stemming from the Floods, Nitrates and Water Framework Directives. Typical approaches used involve a combination of regulation, financial incentives and advice provision. There are also a range of tools that can be used to model the potential effects of mitigation measures and a number of research programmes generating findings that may be of value to the landscape planner

Formulation of a dry powder influenza vaccine for nasal delivery

The purpose of this research was to prepare a dry powder vaccine formulation containing whole inactivated influenza virus (VIIV) and a mucoadhesive compound suitable for nasal delivery. Powders containing WIIV and either lactose or trehalose were produced by lyophilization. A micro-ball mill was used to reduce the lyophilized cake to sizes suitable for nasal delivery. Chitosan flakes were reduced in size using a cryo-milling technique. Milled powders were sieved between 45 and 125 μm aggregate sizes and characterized for particle size and distribution, morphology, and flow properties. Powders were blended in the micro-ball mill without the ball. Lyophilization followed by milling produced irregularly shaped, polydisperse particles with a median primary particle diameter of ≈21 μm and a yield of ≈37% of particles in the 45 to 125 μm particle size range. Flow properties of lactose and trehalose powders after lyophilization followed by milling and sieving were similar. Cryo-milling produced a small yield of particles in the desired size range (<10%). Lyophilization followed by milling and sieving produced particles suitable for nasal delivery with different physicochemical properties as a function of processing conditions and components of the formulation. Further optimization of particle size and morphology is required for these powders to be suitable for clinical evaluation